AURKA and neuroblastoma: Different aurora kinase inhibitors including the aurora kinase A inhibitors MLN8054 and alisertib (MLN8237), the aurora kinase B inhibitor AZD1152, and the pan aurora kinase inhibitor CCT137690 were demonstrated to display anti-neuroblastoma activity [5], [7]–[15].